MedTrace Logo

Cognitive Therapy for Distressing Visual Hallucinations: A Pilot Study

NCT02782507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2017-10-31

No results posted yet for this study

Summary

The study is a pilot study of Cognitive therapy for people with psychosis who have distressing visual hallucinations. The aim is to evaluate whether this is an acceptable, feasible and effective treatment. This is a pilot study and there is no randomisation to either CBT or treatment as usual (TAU). If a participant is allocated to the cognitive therapy plus TAU condition then the participant will meet with a therapist on initially a weekly basis and receive up to 8 sessions of CBT over a 2 month period. The participant will also have regular assessments conducted by a researcher who is independent to the treatment group. It is predicted that those people receiving CBT will improve on measures of symptoms, and particularly for measures of visual hallucinations.

Conditions

  • Visual Hallucinations
  • Psychotic Disorders

Interventions

BEHAVIORAL

CBT for Distressing visual hallucinations

Eight to ten sessions of manualised CBT for distressing visual hallucinations based on existing treatment manuals (ie. Kingdon \& Turkington, 2004, Morrison et al., 2005), delivered over 8 to 12 weeks by CBT therapists. Subjects will continue to receive treatment as usual throughout the therapy period and will receive appropriate prescription of medication if requested or clinically indicated.

Sponsors & Collaborators

  • Northumberland, Tyne and Wear NHS Foundation Trust

    collaborator OTHER

  • Newcastle University

    lead OTHER

Principal Investigators

  • Robert Dudley, Ph.D · Newcastle University

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02782507 on ClinicalTrials.gov